Toronto, Ontario, August 11, 2016 – Mettrum Health Corp. (“Mettrum” or the “Company”) (TSXV:MT), a vertically integrated provider of cannabis products, is pleased to respond to today’s announcement by Health Canada that new regulations governing the production of medical cannabis in Canada. The Access to Cannabis for Medical Purposes Regulations (ACMPR) will come into effect on August 24th and replaces the existing Marihuana for Medical Purposes Regulations. The ACMPR provides options for patients who require medical cannabis.
This announcement reaffirms that the only commercial providers of medical cannabis are Canada’s current licensed producers (LPs). Patients who wish to grow, or designate a grower, will need to receive a doctor’s authorization to use cannabis for medical purposes, register with Health Canada, and to comply with all municipal by-laws and regulations.
“As in other industries, we do not anticipate DIY growing and designated DIY to have any impact on our ability to achieve our business objectives,” said Michael Haines, CEO, Mettrum Health Corp. “Cannabis is an evolving industry in Canada. It is a time of change and as a leading licensed producer Mettrum has always been at the forefront of opportunities created by regulatory change.”
Mettrum will continue to be an industry leader that offers a wide variety of high-quality, regulated cannabis products and strains; trained and informed client service; convenient ordering and delivery; and affordable pricing – including an assisted pricing program for clients in need.
About Mettrum Health Corp.
Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the Marihuana for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR"), which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for Mettrum Ltd. at its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company's three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum’s functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).
For further information, please contact:
Mettrum Health Corp.
Director, Investor Relations
Argyle Public Relationships
416-968-7311 ext. 236
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this press release.